PhD-trained scientist and a PMP-certified product development leader with over 30 years of international experience in programs ranging from early stage to lifecycle management in multiple TA and multiple modalities.
The recent overturning of Chevron has significant implications, particularly for Herring Fisherman, the central focus of the case. While the impact on the FDA may be overstated by some, the decision highlights the need for agencies to ensure their rulings are both correct and reasonable. This shift places more responsibility on agencies to interpret and enforce laws accurately. The bright side is the potential prevention of unelected bureaucrats overstepping their bounds, despite the likelihood of an increase in court cases. Find out more from Andy Fois of the Federal News Network: https://lnkd.in/eise-eCz